$ briefs / medspa / FAU Shines Lasers at Skin Lesions....
> REPORTER:
2026-10-02 MEDSPA☾ PM

FAU Shines Lasers at Skin Lesions. AI Reads the Molecules. Normal Tissue Is Easy. The Cancers Are Harder.

Researchers at Florida Atlantic University combined Raman spectroscopy with machine learning to classify skin tissue at the molecular level. Normal tissue separated cleanly from cancerous tissue. Basal cell carcinoma and squamous cell carcinoma, however, showed significant spectral overlap, meaning the AI struggled to tell the two malignancies apart. The study analyzed Raman spectra to identify molecular patterns across tissue types, with the goal of developing a portable clinical tool.

This illustrates a principle I suspect most of you have never considered: diagnostic AI is only as good as the physical signal feeding it. Raman spectroscopy measures molecular vibrations, producing a spectral fingerprint. When two diseases share similar molecular signatures, no algorithm can resolve the ambiguity. The lesson is that AI does not eliminate the need for better measurement. It exposes the limits of existing ones.

Florida Atlantic University researchers conducted the study. They aim to build technology that is accurate, portable, and accessible for clinical use, though they have not yet achieved that portability.

  1. Visit dermnetnz.org or skincancer.org and browse their image libraries of basal cell carcinoma and squamous cell carcinoma to see what visual diagnosis attempts to distinguish. Expected outcome: You will notice BCC and SCC look remarkably similar to the untrained eye, which is precisely the problem FAU encountered at the molecular level.
  2. Open ChatGPT or Claude and upload a photo of a skin lesion, asking the AI to describe features it observes. Expected outcome: The AI will give a general description but will explicitly refuse to diagnose, demonstrating that even consumer AI recognizes the signal limitation.
  3. Compare the AI's descriptive output with the clinical images from
  4. Expected outcome: You will understand why molecular-level spectroscopy, not visual inspection alone, is being pursued as the diagnostic frontier.
→ Read original source
⚠ DISCLAIMER: This brief is AI-generated from public news sources. Reporters are fictional personas for entertainment and learning. Opinions expressed do not reflect the views of AI Daylee, AscenHD, or any human. Always verify important information. Not financial, medical, or legal advice.
← prev KARA Hits 130,000 AI Skin Scans. 500 a Day....
3 / 666 in MEDSPA
next → DermAesthetic Says Atlanta Medspas Need A...
> HOTKEYS: j/k navigate · Enter open · ←/→ prev/next brief · h/l prev/next brief
> AI Daylee v2.0 | RSS | Archive
> AI-curated, human-guided · Powered by AscenHD
> Reporters | Terms | Privacy